Presentation is loading. Please wait.

Presentation is loading. Please wait.

Number of Monthly Ezetimibe Prescriptions in the United States and Canada from 2002 to 2006 Data are from the National Prescription Audit of IMS Health.

Published byElwin Watson Modified over 5 years ago

Similar presentations

Presentation on theme: "Number of Monthly Ezetimibe Prescriptions in the United States and Canada from 2002 to 2006 Data are from the National Prescription Audit of IMS Health."— Presentation transcript:

1 Number of Monthly Ezetimibe Prescriptions in the United States and Canada from 2002 to 2006
Data are from the National Prescription Audit of IMS Health United States and the Canadian CompuScript Audit of IMS Health Canada. The scale for the number of prescriptions in Panel A is higher than that in Panel B by a factor of 10. Census estimates for 2001 are approximately 285 million for the United States and 30 million for Canada. Jackevicius CA, et al. N Engl J Med 2008;358: [Epub Mar 30]

2 Standardized Annual Volume of Prescriptions for Ezetimibe, Statins, and All Lipid-Lowering Agents per 100,000 Persons, According to Country Data are from the National Prescription Audit of IMS Health United States and the Canadian CompuScript Audit of IMS Health Canada. Numbers have been standardized to the population on the basis of census data from the United States and Canada for 2001. Jackevicius CA, et al. NEJM 2008;358: [Epub Mar 30]

3 Annual Expenditures on Prescriptions for Lipid-Lowering Agents, According to Drug Class*
Jackevicius CA, et al. N Engl J Med 2008;358: [Epub Mar 30]

4 Number of Monthly Ezetimibe Prescriptions in the United States and Canada from 2002 to 2006
Jackevicius CA, et al. N Engl J Med 2008;358: [Epub Mar 30]

5 Standardized Annual Expenditures on Prescriptions for Ezetimibe, Statins, and All Lipid-Lowering Agents per 100,000 Persons, According to Country Data are from the National Prescription Audit of IMS Health United States and the Canadian CompuScript Audit of IMS Health Canada. Costs have been standardized to the population on the basis of census data from the United States and Canada for Costs have been adjusted for purchasing-power parity. Jackevicius CA, et al. NEJM 2008;358: [Epub Mar 30]

Download ppt "Number of Monthly Ezetimibe Prescriptions in the United States and Canada from 2002 to 2006 Data are from the National Prescription Audit of IMS Health."

Similar presentations

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165: 2264-2271.

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:
Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012 Featured Article: Lydia W. Turner, David Nartey, Randall S. Stafford, Sonal Singh, and G.

Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012 Featured Article: Lydia W. Turner, David Nartey, Randall S. Stafford, Sonal Singh, and G.
European drug statistics What is the reason for the differences between the various EU countries Ulrich Schwabe Pharmakologisches Institut der Ruprecht-Karls-Universität.

European drug statistics What is the reason for the differences between the various EU countries Ulrich Schwabe Pharmakologisches Institut der Ruprecht-Karls-Universität.
1 The Budget Impact of Drugs Treating Rare Diseases in Canada: A 2007-2013 MIDAS Sales Data Analysis April 14, 2015 Oral Presentation at the 2015 CADTH.

1 The Budget Impact of Drugs Treating Rare Diseases in Canada: A MIDAS Sales Data Analysis April 14, 2015 Oral Presentation at the 2015 CADTH.
Exhibit 32.1 Five-Year Relative Survival Rates for Cancer in the United States and Canada, 1999 Copyright 2011 Health Administration Press.

Exhibit 32.1 Five-Year Relative Survival Rates for Cancer in the United States and Canada, 1999 Copyright 2011 Health Administration Press.
Global Immunization Performance Update through 2011.

Global Immunization Performance Update through 2011.
1 Canadian Institute for Health Information. National Health Expenditure Highlights 2.

1 Canadian Institute for Health Information. National Health Expenditure Highlights 2.
Exhibit 25.1 Annual Percentage Changes in the Prescription Drug Price Index and Prescription Drug Expenditures, 1980-2009 Copyright 2011 Health Administration.

Exhibit 25.1 Annual Percentage Changes in the Prescription Drug Price Index and Prescription Drug Expenditures, Copyright 2011 Health Administration.
In 2003, Medicaid spent $33.7 billion on drugs (19% of national spending for drugs and more than 10% of the Medicaid budget) Medicaid expenditures ($ billions)

In 2003, Medicaid spent $33.7 billion on drugs (19% of national spending for drugs and more than 10% of the Medicaid budget) Medicaid expenditures ($ billions)
CHOLESTAGEL Health Economics Study México March 7, 2008.

CHOLESTAGEL Health Economics Study México March 7, 2008.
Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92.

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:
Solomon Tesfaye et al N Engl J Med 2005;352:341- 50 Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.
David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.
Presented at The 129th Annual Meeting of the American Public Health Association Atlanta, GA, October 21–25, 2001 Presented by Amanda A. Honeycutt Linda.

Presented at The 129th Annual Meeting of the American Public Health Association Atlanta, GA, October 21–25, 2001 Presented by Amanda A. Honeycutt Linda.
Shalev V, et al. Arch Intern Med 2009; 169:260-268.

Shalev V, et al. Arch Intern Med 2009; 169:
Canadian Study of Health and Aging The Prevalence of Dementia 1991 Baseline Study.

Canadian Study of Health and Aging The Prevalence of Dementia 1991 Baseline Study.
Charlotte Kragelund et al N Engl J Med 2005;352:666- 75 Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.

Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.
Estimates of People with Hepatitis C in Wyoming

Estimates of People with Hepatitis C in Wyoming
Trial profile SAS denotes the Simvastatin in Aortic Stenosis Study

Trial profile SAS denotes the Simvastatin in Aortic Stenosis Study
Estimates of People with Hepatitis C in Virginia

Estimates of People with Hepatitis C in Virginia

Similar presentations

Ads by Google